PharmEnable

We are a spin-out based on ground-breaking researchfrom the University of Cambridge, UK. Jelena is a geneticist and serial entrepreneur, passionate about the potential of biotechnology to improve patients’ lives. Andreas is a life science data analyst who is committed to developing new methods in the field (using AI/ML) and their application, primarily related to chemical biology, drug discovery and in silico toxicology. Tom has spent over 45 years in the biotech and pharmaceutical industry with leading roles from early drug discovery to big pharma and biotech across several therapeutic areas. Keith joins PharmEnable as the Investor Director from Cambridge Enterprise. Avene is a synthetic chemist with extensive experience in developing novel and efficient chemical methods using catalysis to access stereochemically complex molecules. James has over 18 years experience in drug discovery, with expertise in synthetic and medicinal chemistry. Thomas has over 45 years of experience in the pharmaceutical industry with leading roles at AstraZeneca, ALK-Abelló, 7TM Pharma, LEO Pharma and Mind the Byte.